Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Axogen, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference
-
Axogen, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference
-
Immunic, Inc. to Participate in Investor Conferences in August
-
Net Asset Value(s)
-
Aphria Inc. (APHA) Announces Fourth Quarter and Fiscal Year 2020 Results
-
Elemental Royalties Corp. (formerly Fengro Industries Corp.) Completes Business Combination
-
Eloxx Pharmaceuticals to Present at the 40th Annual Canaccord Genuity Virtual Growth Conference on August 13th, 2020
-
Eloxx Pharmaceuticals to Present at the 40th Annual Canaccord Genuity Virtual Growth Conference on August 13th, 2020
-
UPDATE: Canaccord Genuity Starts Marrone Bio Innovations (MBII) at Buy
-
UPDATE: Canaccord Genuity Starts Calyxt Inc. (CLXT) at Buy
-
UPDATE: Canaccord Genuity Starts Beyond Meat Inc. (BYND) at Hold
-
Fortress Announces Normal Course Issuer Bid For Common Shares
-
BioNTech Announces Closing of $512 Million Underwritten Offering of American Depositary Shares
-
BioNTech Announces Closing of $512 Million Underwritten Offering of American Depositary Shares
-
Schultze SPAC (SAMA) Announces Definitive Agreement to Combine with Cannabis Operator Clever Leaves
-
Schultze Special Purpose Acquisition Corp. Announces a Definitive Agreement to Combine with Clever Leaves, a Large-Scale Pharmaceutical-Grade Multi-National Cannabis Operator
-
Recommended All-Cash Takeover Offer of Cardinal Resources by Shandong Gold
-
Jamf Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Jamf Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Twitter, Inc. (TWTR) PT Raised to $40 at Canaccord Genuity
-
Conformis, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference
-
Sustainable Innovation & Health Dividend Fund Files Final Prospectus
-
BeMetals Upsizes Private Placement to $7.5M Due to High Demand
-
GGL Resources Corp. Closes Private Placement
-
Ceros Announces $100M Strategic Investment Led by Sumeru Equity Partners
-
BioNTech Announces Pricing of Upsized Underwritten Offering and Terms of Rights Offering
-
BioNTech Announces Pricing of Upsized Underwritten Offering and Terms of Rights Offering
-
Canaccord Genuity Group Inc. Access to First Quarter Fiscal 2021 Results Information
-
Jamf Holding (JAMF) IPO Opens 77% Higher
-
Mogo to Participate in the Canaccord Genuity Growth Conference
-
Intuitive Surgical (ISRG) PT Raised to $725 at Canaccord Genuity Due to Strong Balance Sheet and COVID Recovery
-
Willdan Announces Dates For Second Quarter 2020 Earnings Release And Upcoming Management Presentation
-
Jamf Holding Corp. (JAMF) Prices 18M Share Upsized IPO at $26/Sh
-
Jamf Announces Upsize and Pricing of its Initial Public Offering
-
Jamf Announces Upsize and Pricing of its Initial Public Offering
-
Net Asset Value(s)
-
BioNTech (BNTX) PT Raised to $97 at Canaccord Genuity
-
BioNTech SE (BNTX) Announces 5M Share Proposed Public Offerings of ADSs and Rights Offering
-
BioNTech Announces Proposed Public Offerings
-
BioNTech Announces Proposed Public Offerings
-
Curaleaf Holdings Announces Closing of C$34.06 Million Private Placement of Subordinate Voting Shares
-
Krystal Biotech Appoints Whitney Ijem as Senior Vice President, Strategy and Business Development
-
Blue Lagoon Engages Canaccord Genuity as Financial Advisors
-
Transaction in Own Shares
-
Appian Schedules Second Quarter 2020 Financial Results Conference Call and Will Present at Upcoming Investor Conferences
-
Appian Schedules Second Quarter 2020 Financial Results Conference Call and Will Present at Upcoming Investor Conferences
-
Troilus Provides Update on New Field Exploration Underway and Major Technical Milestones
-
Apple (AAPL) PT Raised to $444 at Canaccord Genuity As 5G Cycle Nears
-
Atreca (BCEL) Prices 7.031 Class A Share Common Offering at $16/Sh
-
Atreca, Inc. Announces Pricing of Underwritten Public Offering of Common Stock

